financetom
Business
financetom
/
Business
/
GATX's Q1 Non-GAAP Earnings Fall, Revenue Increases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GATX's Q1 Non-GAAP Earnings Fall, Revenue Increases
Apr 23, 2024 6:20 AM

08:53 AM EDT, 04/23/2024 (MT Newswires) -- GATX ( GATX ) reported Q1 non-GAAP earnings Tuesday of $2.01 per diluted share, down from $2.20 a year earlier.

Four analysts polled by Capital IQ expected $1.76.

Total revenue for the quarter ended March 31 was $379.9 million, up from $338.9 million a year earlier.

Three analysts surveyed by Capital IQ expected $376.1 million.

The company said it maintained its 2024 earnings guidance of $7.30 to $7.70 per diluted share. Four analysts surveyed by Capital IQ expect $7.56.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Marsh & Mclennan Companies Insider Sold Shares Worth $1,254,070, According to a Recent SEC Filing
Marsh & Mclennan Companies Insider Sold Shares Worth $1,254,070, According to a Recent SEC Filing
Jun 17, 2024
04:06 PM EDT, 06/17/2024 (MT Newswires) -- Oscar Fanjul, Director, on June 13, 2024, sold 6,000 shares in Marsh & Mclennan Companies ( MMC ) for $1,254,070. Following the Form 4 filing with the SEC, Fanjul has control over a total of 53,393 shares of the company, with 53,393 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/62709/000112760224018811/xslF345X03/form4.xml Price: 211.52, Change: -0.07, Percent...
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,596,400, According to a Recent SEC Filing
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,596,400, According to a Recent SEC Filing
Jun 17, 2024
04:05 PM EDT, 06/17/2024 (MT Newswires) -- Michael S Brown, Director, on June 14, 2024, sold 1,535 shares in Regeneron Pharmaceuticals ( REGN ) for $1,596,400. Following the Form 4 filing with the SEC, Brown has control over a total of 12,544 shares of the company, with 1,382 shares held directly and 11,162 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/872589/000196820224000102/xslF345X03/edgardoc.xml ...
Adobe Accused of Using Deceptive Practices Over Fees, Handling of Subscription Cancellations
Adobe Accused of Using Deceptive Practices Over Fees, Handling of Subscription Cancellations
Jun 17, 2024
04:10 PM EDT, 06/17/2024 (MT Newswires) -- Adobe (ADBE) on Monday was accused by the Federal Trade Commission of using deceptive practices to hide termination fees and preventing customers from easily cancelling their subscriptions to the company's Photoshop and Acrobat software programs. In a complaint filed by the Department of Justice with the US District Court for the Northern District...
Nike Unusual Options Activity
Nike Unusual Options Activity
Jun 17, 2024
Investors with a lot of money to spend have taken a bullish stance on Nike ( NKE ) . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big...
Copyright 2023-2026 - www.financetom.com All Rights Reserved